Simó Schwartz
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
-
- Genetic factors in colorectal cancer
Papers in
-
- RNA Interference and Gene Delivery 13
- Epigenetics and DNA Methylation 9
- Glycosylation and Glycoproteins Research 7
- Oncology 34
- Cancer Cells and Metastasis 14
- Co-authors
- Ibane Abasolo (57 shared papers)Diego Arango (34 shared papers)Hiroyuki Yamamoto (10 shared papers)Diana Rafael (31 shared papers)Fernanda Andrade (26 shared papers)Lauri A. Aaltonen (11 shared papers)Hafid Alazzouzi (10 shared papers)Yolanda Fernández (18 shared papers)
- Journals
- Oncogene (7 papers)Pharmaceutics (6 papers)International Journal of Cancer (5 papers)Nanomedicine Nanotechnology Biology and Medicine (5 papers)Clinical Cancer Research (5 papers)
- Partner nations
- SpainPortugalUnited States
In The Last Decade
Simó Schwartz
144 papers receiving 6.1k citations
Peers
Comparison fields: 5 of 141
- Cancer Research 930
- Pathology and Forensic Medicine 948
- Oncology 1.4k
- Biomaterials 711
- Molecular Biology 3.0k
Countries citing papers authored by Simó Schwartz
This map shows the geographic impact of Simó Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simó Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simó Schwartz more than expected).
Fields of papers citing papers by Simó Schwartz
This network shows the impact of papers produced by Simó Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simó Schwartz. The network helps show where Simó Schwartz may publish in the future.
Co-authors
The 25 scholars most cited alongside Simó Schwartz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 328 | |
| 2 | 2005 | 297 | |
| 3 | 2010 | 279 | |
| 4 | 2006 | 234 | |
| 5 | Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. | 1999 | 193 |
| 6 | 2002 | 185 | |
| 7 | 2021 | 173 | |
| 8 | 2005 | 160 | |
| 9 | 2006 | 147 | |
| 10 | 2005 | 138 | |
| 11 | Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microsatellite instability. | 2001 | 132 |
| 12 | 2006 | 123 | |
| 13 | 2003 | 121 | |
| 14 | 2017 | 110 | |
| 15 | 2012 | 108 | |
| 16 | 2005 | 108 | |
| 17 | 2006 | 100 | |
| 18 | 2011 | 96 | |
| 19 | 2020 | 89 | |
| 20 | 2005 | 84 |
About Simó Schwartz
Simó Schwartz is a scholar working on Molecular Biology, Oncology, Biomaterials, Pathology and Forensic Medicine and Cancer Research, having authored 145 papers that have together received 6.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (23 papers), Genetic factors in colorectal cancer (18 papers), Cancer Cells and Metastasis (14 papers), RNA Interference and Gene Delivery (13 papers), Epigenetics and DNA Methylation (9 papers), Cancer Genomics and Diagnostics (8 papers), Nanoplatforms for cancer theranostics (8 papers) and Glycosylation and Glycoproteins Research (7 papers). The work is most often cited by research in Cancer Research (930 citations), Pathology and Forensic Medicine (948 citations), Oncology (1.4k citations), Biomaterials (711 citations) and Molecular Biology (3.0k citations). Simó Schwartz has collaborated with scholars based in Spain, Portugal and United States. Frequent co-authors include Ibane Abasolo, Diego Arango, Hiroyuki Yamamoto, Diana Rafael, Fernanda Andrade, Lauri A. Aaltonen, Hafid Alazzouzi, Yolanda Fernández, Raquel Seruca and Carla Oliveíra. Their work appears in journals such as Oncogene, Pharmaceutics, International Journal of Cancer, Nanomedicine Nanotechnology Biology and Medicine and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.